Literature DB >> 16766423

Tobacco-specific nitrosamines in new tobacco products.

Irina Stepanov1, Joni Jensen, Dorothy Hatsukami, Stephen S Hecht.   

Abstract

New tobacco products, designed to attract consumers who are concerned about the health effects of tobacco, have been appearing on the market. Objective evaluation of these products requires, as a first step, data on their potentially toxic constituents. Tobacco-specific nitrosamines (TSNAs) are an important class of carcinogens in tobacco products, but virtually no data were available on their levels in these products. In the present study, we analyzed several new products-Ariva, Stonewall, Exalt, Revel, Smokey Mountain, and Quest-for TSNAs and compared their TSNA levels with those in nicotine replacement products and conventional smokeless tobacco and cigarette brands. TSNAs were not detected in Smokey Mountain, which is a tobacco-free snuff product. The lowest levels among the new products containing tobacco were in Ariva and Stonewall (0.26-0.28 microg/g wet weight of product). The highest levels in the new products were found in Exalt (3.3 microg/g tobacco), whereas Revel and Quest had intermediate amounts. Only trace amounts were found in nicotine replacement products, and conventional brands had levels consistent with those reported in the literature. These results demonstrate that TSNA levels in new tobacco products range from relatively low to comparable with those found in some conventional brands.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766423     DOI: 10.1080/14622200500490151

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  57 in total

1.  Smokeless tobacco brand switching: a means to reduce toxicant exposure?

Authors:  D K Hatsukami; J O Ebbert; A Anderson; H Lin; C Le; S S Hecht
Journal:  Drug Alcohol Depend       Date:  2006-09-20       Impact factor: 4.492

Review 2.  Nicotine reduction revisited: science and future directions.

Authors:  Dorothy K Hatsukami; Kenneth A Perkins; Mark G Lesage; David L Ashley; Jack E Henningfield; Neal L Benowitz; Cathy L Backinger; Mitch Zeller
Journal:  Tob Control       Date:  2010-10       Impact factor: 7.552

3.  Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology.

Authors:  Jennifer N Gray; Alison B Breland; Michael Weaver; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2008-09       Impact factor: 4.244

4.  Biomarkers of Exposure among Adult Smokeless Tobacco Users in the Population Assessment of Tobacco and Health Study (Wave 1, 2013-2014).

Authors:  Yu-Ching Cheng; Carolyn M Reyes-Guzman; Carol H Christensen; Brian L Rostron; Kathryn C Edwards; Lanqing Wang; Jun Feng; Jeffery M Jarrett; Cynthia D Ward; Baoyun Xia; Heather L Kimmel; Kevin Conway; Carmine Leggett; Kristie Taylor; Charlie Lawrence; Ray Niaura; Mark J Travers; Andrew Hyland; Stephen S Hecht; Dorothy K Hatsukami; Maciej L Goniewicz; Nicolette Borek; Benjamin C Blount; Dana M van Bemmel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-01-27       Impact factor: 4.254

5.  A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: changes in smoking behavior and readiness to quit.

Authors:  Matthew J Carpenter; Kevin M Gray
Journal:  Nicotine Tob Res       Date:  2010-01-06       Impact factor: 4.244

6.  Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products.

Authors:  Irina Stepanov; Steven G Carmella; Anna Briggs; Louise Hertsgaard; Bruce Lindgren; Dorothy Hatsukami; Stephen S Hecht
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

7.  Carcinogenic tobacco-specific N-nitrosamines in US cigarettes: three decades of remarkable neglect by the tobacco industry.

Authors:  Irina Stepanov; Aleksandar Knezevich; Liqin Zhang; Clifford H Watson; Dorothy K Hatsukami; Stephen S Hecht
Journal:  Tob Control       Date:  2011-05-20       Impact factor: 7.552

Review 8.  The association between smokeless tobacco use and pancreatic adenocarcinoma: a systematic review.

Authors:  Matthew D Burkey; Shari Feirman; Han Wang; Samuel Ravi Choudhury; Surbhi Grover; Fabian M Johnston
Journal:  Cancer Epidemiol       Date:  2014-09-26       Impact factor: 2.984

Review 9.  Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example.

Authors:  Richard J O'Connor; K Michael Cummings; Vaughan W Rees; Gregory N Connolly; Kaila J Norton; David Sweanor; Mark Parascandola; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

10.  A Survey of N'-Nitrosonornicotine (NNN) and Total Water Content in Select Smokeless Tobacco Products Purchased in the United States in 2015.

Authors:  Jeffrey R Ammann; Katherine S Lovejoy; Matthew J Walters; Matthew R Holman
Journal:  J Agric Food Chem       Date:  2016-05-18       Impact factor: 5.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.